https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e17005)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e17005)2019-05-31 00:00:002019-05-31 00:00:00Dynamics of the immune status in patients with cervical cancer receiving complex treatment with dendritic cell vaccine.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e15748)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e15748)2019-05-31 00:00:002020-05-06 15:03:38Combination therapy of dendritic cell vaccination plus chemotherapy in pancreatic cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e21024)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e21024)2019-05-31 00:00:002020-05-06 15:04:34Dendritic cell vaccination in metastatic uveal melanoma as compassionate treatment: Immunological and clinical responses.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / Melanoma Manag 2019 May;6(2):MMT20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / Melanoma Manag 2019 May;6(2):MMT202019-05-31 00:00:002019-05-31 00:00:00Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-14 / BMJ Open 2019 05;9(5):e026779
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-14 / BMJ Open 2019 05;9(5):e0267792019-05-14 00:00:002019-05-14 00:00:00Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-30 / Mol Immunol 2019 07;111:106-117
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-30 / Mol Immunol 2019 07;111:106-1172019-04-30 00:00:002020-12-07 11:34:33A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-29 / Int. J. Cancer 2019 10;145(7):1958-1969
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-29 / Int. J. Cancer 2019 10;145(7):1958-19692019-04-29 00:00:002020-08-26 14:13:53Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-27 / Trials 2019 Apr;20(1):242
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-27 / Trials 2019 Apr;20(1):2422019-04-27 00:00:002021-05-19 15:22:19A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-27 / J Clin Med 2019 Apr;8(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-27 / J Clin Med 2019 Apr;8(5)2019-04-27 00:00:002019-04-27 00:00:00Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-24 / Front Immunol 2019;10:874
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-24 / Front Immunol 2019;10:8742019-04-24 00:00:002019-04-24 00:00:00Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
